Cargando…

Prevalence of cardiometabolic risk factors and metabolic syndrome in obese Kuwaiti adolescents

BACKGROUND: Childhood and adolescent obesity is associated with insulin resistance, abnormal glucose metabolism, hypertension, dyslipidemia, inflammation, liver disease, and compromised vascular function. The purpose of this pilot study was to determine the prevalence of cardiometabolic risk factor...

Descripción completa

Detalles Bibliográficos
Autores principales: Boodai, Shurooq A, Cherry, Lynne M, Sattar, Naveed A, Reilly, John J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4216021/
https://www.ncbi.nlm.nih.gov/pubmed/25368527
http://dx.doi.org/10.2147/DMSO.S66156
_version_ 1782342195167100928
author Boodai, Shurooq A
Cherry, Lynne M
Sattar, Naveed A
Reilly, John J
author_facet Boodai, Shurooq A
Cherry, Lynne M
Sattar, Naveed A
Reilly, John J
author_sort Boodai, Shurooq A
collection PubMed
description BACKGROUND: Childhood and adolescent obesity is associated with insulin resistance, abnormal glucose metabolism, hypertension, dyslipidemia, inflammation, liver disease, and compromised vascular function. The purpose of this pilot study was to determine the prevalence of cardiometabolic risk factor abnormalities and metabolic syndrome (MetS) in a sample of obese Kuwaiti adolescents, as prevalence data might be helpful in improving engagement with obesity treatment in future. METHODS: Eighty obese Kuwaiti adolescents (40 males) with a mean (standard deviation) age of 12.3 years (1.1 years) participated in the present study. All participants had a detailed clinical examination and anthropometry, blood pressure taken, and assessment of fasting levels of C-reactive protein, intracellular adhesion molecule, interleukin-6, fasting blood glucose, insulin, liver function tests (alanine aminotransferase, aspartate aminotransferase, gamma glutamyltransferase), lipid profile (cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides), insulin resistance by homeostasis model assessment, and adiponectin. MetS was assessed using two recognized criteria modified for use in younger individuals. RESULTS: The cardiometabolic risk factors with highest prevalence of abnormal values included aspartate aminotransferase (88.7% of the sample) and insulin resistance by homeostasis model assessment (67.5%), intracellular adhesion molecule (66.5%), fasting insulin (43.5%), C-reactive protein (42.5%), low-density lipoprotein cholesterol (35.0%), total cholesterol (33.5%), and systolic blood pressure (30.0%). Of all participants, 96.3% (77/80) had at least one impaired cardiometabolic risk factor as well as obesity. Prevalence of MetS was 21.3% according to the International Diabetes Federation definition and 30% using the Third Adult Treatment Panel definition. CONCLUSION: The present study suggests that obese Kuwaiti adolescents have multiple cardiometabolic risk factor abnormalities. Future studies are needed to test the benefits of intervention in this high-risk group. They also suggest that prevention of obesity in children and adults should be a major public health goal in Kuwait.
format Online
Article
Text
id pubmed-4216021
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-42160212014-11-03 Prevalence of cardiometabolic risk factors and metabolic syndrome in obese Kuwaiti adolescents Boodai, Shurooq A Cherry, Lynne M Sattar, Naveed A Reilly, John J Diabetes Metab Syndr Obes Original Research BACKGROUND: Childhood and adolescent obesity is associated with insulin resistance, abnormal glucose metabolism, hypertension, dyslipidemia, inflammation, liver disease, and compromised vascular function. The purpose of this pilot study was to determine the prevalence of cardiometabolic risk factor abnormalities and metabolic syndrome (MetS) in a sample of obese Kuwaiti adolescents, as prevalence data might be helpful in improving engagement with obesity treatment in future. METHODS: Eighty obese Kuwaiti adolescents (40 males) with a mean (standard deviation) age of 12.3 years (1.1 years) participated in the present study. All participants had a detailed clinical examination and anthropometry, blood pressure taken, and assessment of fasting levels of C-reactive protein, intracellular adhesion molecule, interleukin-6, fasting blood glucose, insulin, liver function tests (alanine aminotransferase, aspartate aminotransferase, gamma glutamyltransferase), lipid profile (cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides), insulin resistance by homeostasis model assessment, and adiponectin. MetS was assessed using two recognized criteria modified for use in younger individuals. RESULTS: The cardiometabolic risk factors with highest prevalence of abnormal values included aspartate aminotransferase (88.7% of the sample) and insulin resistance by homeostasis model assessment (67.5%), intracellular adhesion molecule (66.5%), fasting insulin (43.5%), C-reactive protein (42.5%), low-density lipoprotein cholesterol (35.0%), total cholesterol (33.5%), and systolic blood pressure (30.0%). Of all participants, 96.3% (77/80) had at least one impaired cardiometabolic risk factor as well as obesity. Prevalence of MetS was 21.3% according to the International Diabetes Federation definition and 30% using the Third Adult Treatment Panel definition. CONCLUSION: The present study suggests that obese Kuwaiti adolescents have multiple cardiometabolic risk factor abnormalities. Future studies are needed to test the benefits of intervention in this high-risk group. They also suggest that prevention of obesity in children and adults should be a major public health goal in Kuwait. Dove Medical Press 2014-10-24 /pmc/articles/PMC4216021/ /pubmed/25368527 http://dx.doi.org/10.2147/DMSO.S66156 Text en © 2014 Boodai et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Boodai, Shurooq A
Cherry, Lynne M
Sattar, Naveed A
Reilly, John J
Prevalence of cardiometabolic risk factors and metabolic syndrome in obese Kuwaiti adolescents
title Prevalence of cardiometabolic risk factors and metabolic syndrome in obese Kuwaiti adolescents
title_full Prevalence of cardiometabolic risk factors and metabolic syndrome in obese Kuwaiti adolescents
title_fullStr Prevalence of cardiometabolic risk factors and metabolic syndrome in obese Kuwaiti adolescents
title_full_unstemmed Prevalence of cardiometabolic risk factors and metabolic syndrome in obese Kuwaiti adolescents
title_short Prevalence of cardiometabolic risk factors and metabolic syndrome in obese Kuwaiti adolescents
title_sort prevalence of cardiometabolic risk factors and metabolic syndrome in obese kuwaiti adolescents
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4216021/
https://www.ncbi.nlm.nih.gov/pubmed/25368527
http://dx.doi.org/10.2147/DMSO.S66156
work_keys_str_mv AT boodaishurooqa prevalenceofcardiometabolicriskfactorsandmetabolicsyndromeinobesekuwaitiadolescents
AT cherrylynnem prevalenceofcardiometabolicriskfactorsandmetabolicsyndromeinobesekuwaitiadolescents
AT sattarnaveeda prevalenceofcardiometabolicriskfactorsandmetabolicsyndromeinobesekuwaitiadolescents
AT reillyjohnj prevalenceofcardiometabolicriskfactorsandmetabolicsyndromeinobesekuwaitiadolescents